Azenta, Inc. (LON:0HQ1)
London · Delayed Price · Currency is GBP · Price in USD 30.71
+0.22 (0.73%)
At close: Oct 14, 2025
Azenta Market Cap
Azenta has a market cap or net worth of 1.08 billion as of October 17, 2025. Its market cap has decreased by -38.57% in one year.
Market Cap
1.08B
Enterprise Value
711.53M
Revenue
488.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.71
Market Cap Chart
Since February 2, 1995, Azenta's market cap has increased from 21.97M to 1.08B, an increase of 4,794.44%. That is a compound annual growth rate of 13.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 1.08B | -41.08% |
| Dec 31, 2024 | 1.82B | -35.96% |
| Dec 29, 2023 | 2.85B | -14.60% |
| Dec 30, 2022 | 3.34B | -41.51% |
| Dec 31, 2021 | 5.70B | 54.68% |
| Dec 31, 2020 | 3.69B | 58.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 197.53B |
| GSK plc | 65.86B |
| Haleon | 30.59B |
| Smith & Nephew | 11.11B |
| ConvaTec Group | 4.84B |
| Hikma Pharmaceuticals | 3.98B |
| HUTCHMED (China) | 1.97B |
| Genus | 1.78B |